Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozole.
Authors
Howell, AnthonyAffiliation
Manchester Breast Centre, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK.Issue Date
2012-04
Metadata
Show full item recordCitation
Genesis and outcome of a breast cancer trial to develop the aromatase inhibitor anastrozole. 2012, 58 (4):782-3 Clin ChemJournal
Clinical ChemistryDOI
10.1373/clinchem.2011.181206PubMed ID
22334481Type
ArticleLanguage
enISSN
1530-8561ae974a485f413a2113503eed53cd6c53
10.1373/clinchem.2011.181206
Scopus Count
Collections
Related articles
- The adjuvant endocrine treatment revolution: focus on anastrozole.
- Authors: Jakesz R
- Issue date: 2006 Apr
- Promising switch to anastrozole for breast-cancer treatment.
- Authors: Chen V
- Issue date: 2005 Sep
- Anastrozole for breast cancer: recent advances and ongoing challenges.
- Authors: Buzdar AU
- Issue date: 2006 Jun
- Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
- Authors: Grana G
- Issue date: 2006 Jun 1
- Aromatase inhibitors in the treatment of early and advanced breast cancer.
- Authors: Joensuu H, Ejlertsen B, Lønning PE, Rutqvist LE
- Issue date: 2005